IL142063A0 - Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same - Google Patents

Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL142063A0
IL142063A0 IL14206399A IL14206399A IL142063A0 IL 142063 A0 IL142063 A0 IL 142063A0 IL 14206399 A IL14206399 A IL 14206399A IL 14206399 A IL14206399 A IL 14206399A IL 142063 A0 IL142063 A0 IL 142063A0
Authority
IL
Israel
Prior art keywords
tetrahydropyridoether
derivatives
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL14206399A
Other languages
English (en)
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of IL142063A0 publication Critical patent/IL142063A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14206399A 1998-09-23 1999-09-17 Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same IL142063A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19843504 1998-09-23
EP98117988 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (1)

Publication Number Publication Date
IL142063A0 true IL142063A0 (en) 2002-03-10

Family

ID=26049024

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14206399A IL142063A0 (en) 1998-09-23 1999-09-17 Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same
IL142063A IL142063A (en) 1998-09-23 2001-03-18 History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142063A IL142063A (en) 1998-09-23 2001-03-18 History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them

Country Status (31)

Country Link
US (4) US6436953B1 (sk)
EP (1) EP1115725B1 (sk)
JP (1) JP4145492B2 (sk)
KR (1) KR100668400B1 (sk)
CN (2) CN100506821C (sk)
AT (1) ATE231862T1 (sk)
AU (1) AU763463B2 (sk)
BG (1) BG65195B1 (sk)
BR (1) BR9914044A (sk)
CA (1) CA2344251A1 (sk)
CZ (1) CZ292335B6 (sk)
DE (1) DE69905178T2 (sk)
DK (1) DK1115725T3 (sk)
EA (1) EA005377B1 (sk)
EE (1) EE04677B1 (sk)
ES (1) ES2191464T3 (sk)
GE (1) GEP20032926B (sk)
HK (1) HK1038360B (sk)
HR (1) HRP20010224A2 (sk)
HU (1) HUP0102990A3 (sk)
ID (1) ID28896A (sk)
IL (2) IL142063A0 (sk)
NO (1) NO317304B1 (sk)
NZ (1) NZ510610A (sk)
PL (1) PL193616B1 (sk)
PT (1) PT1115725E (sk)
RS (1) RS50145B (sk)
SI (1) SI1115725T1 (sk)
SK (1) SK285165B6 (sk)
TR (1) TR200100805T2 (sk)
WO (1) WO2000017200A1 (sk)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE04677B1 (et) 1998-09-23 2006-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahdropridoeetrid, nende kasutamine ja ravim
AU3966600A (en) * 1999-04-17 2000-11-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Haloalkoxy imidazonaphthyridines
CA2721484A1 (en) * 1999-05-12 2000-11-12 President And Fellows Of Harvard College Dopamine transporter imaging agents
ES2253376T3 (es) * 2000-03-29 2006-06-01 Altana Pharma Ag Profarmacos de derivados de imidazopiridina.
MXPA02009549A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Imidazopiridinas triciclicas.
US6869949B2 (en) * 2000-10-25 2005-03-22 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MXPA03007888A (es) * 2001-03-08 2003-12-04 Astrazeneca Ab Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
PL366658A1 (en) 2001-08-02 2005-02-07 Altana Pharma Ag Tricyclic epoxides
BR0211620A (pt) * 2001-08-03 2004-08-24 Altana Pharma Ag Imidazopiridinas substituìdas por alquila para o tratamento de distúrbios gastrointestinais
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
EA008375B1 (ru) 2002-02-15 2007-04-27 Алтана Фарма Аг Трициклические n-ацильные соединения
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
RS95304A (en) * 2002-05-07 2006-12-15 Altana Pharma Ag. New combination fortreating airway disorders
MXPA05005117A (es) 2002-11-19 2005-07-01 Altana Pharma Ag Imidazopiridinas 8-sustituidas.
DK1572217T3 (da) 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
CA2509882A1 (en) * 2002-12-20 2004-07-08 Altana Pharma Ag Silyl ethers
US20060154954A1 (en) * 2003-02-17 2006-07-13 Altana Pharma Ag Combinations and use of selected pharmaceutically active compounds
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
MXPA05012463A (es) * 2003-05-27 2006-01-30 Altana Pharma Ag Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
AU2004268641A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
CN1874772A (zh) * 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
US7326784B2 (en) 2003-12-19 2008-02-05 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
KR100958828B1 (ko) 2004-09-03 2010-05-24 주식회사유한양행 피롤로[3,2-ｂ]피리딘 유도체 및 그의 제조방법
WO2006025714A1 (en) 2004-09-03 2006-03-09 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
CA2579087C (en) 2004-09-03 2012-05-01 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
EP2452680B1 (en) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
EP2861571B1 (en) * 2012-06-15 2017-05-03 Bio-Pharm Solutions Co., Ltd. Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
US20160235724A1 (en) 2013-10-08 2016-08-18 Katairo Gmbh Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
US5112834A (en) 1987-07-16 1992-05-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazole protectorant for the stomach and intestine
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
EP0773945A1 (de) * 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Acylimidazopyridine
DE69823493T2 (de) * 1997-03-24 2009-09-24 Nycomed Gmbh Tetrahydropyridoverbindungen
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
EE04677B1 (et) 1998-09-23 2006-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahdropridoeetrid, nende kasutamine ja ravim

Also Published As

Publication number Publication date
EA200100315A1 (ru) 2001-10-22
SK3992001A3 (en) 2001-12-03
US7105676B2 (en) 2006-09-12
ID28896A (id) 2001-07-12
EP1115725A1 (en) 2001-07-18
JP2002526499A (ja) 2002-08-20
CN100506821C (zh) 2009-07-01
TR200100805T2 (tr) 2001-08-21
AU6192099A (en) 2000-04-10
JP4145492B2 (ja) 2008-09-03
CZ20011082A3 (cs) 2001-09-12
CA2344251A1 (en) 2000-03-30
SK285165B6 (sk) 2006-07-07
HK1038360A1 (en) 2002-03-15
YU21401A (sh) 2004-03-12
IL142063A (en) 2007-10-31
EA005377B1 (ru) 2005-02-24
NZ510610A (en) 2003-07-25
SI1115725T1 (en) 2003-06-30
HK1038360B (zh) 2003-05-16
CN1155598C (zh) 2004-06-30
NO317304B1 (no) 2004-10-04
HUP0102990A3 (en) 2002-09-30
KR20010075223A (ko) 2001-08-09
BG65195B1 (bg) 2007-06-29
BR9914044A (pt) 2001-12-04
HRP20010224A2 (en) 2002-04-30
PL346617A1 (en) 2002-02-25
US7393860B1 (en) 2008-07-01
PL193616B1 (pl) 2007-02-28
HUP0102990A2 (hu) 2002-01-28
DE69905178D1 (de) 2003-03-06
RS50145B (sr) 2009-03-25
DK1115725T3 (da) 2003-06-23
NO20011243L (no) 2001-03-12
US6436953B1 (en) 2002-08-20
BG105270A (en) 2001-11-30
CZ292335B6 (cs) 2003-09-17
KR100668400B1 (ko) 2007-01-17
EE200100172A (et) 2002-06-17
EP1115725B1 (en) 2003-01-29
CN1319101A (zh) 2001-10-24
DE69905178T2 (de) 2003-07-17
ES2191464T3 (es) 2003-09-01
WO2000017200A1 (en) 2000-03-30
US6696460B2 (en) 2004-02-24
EE04677B1 (et) 2006-08-15
AU763463B2 (en) 2003-07-24
ATE231862T1 (de) 2003-02-15
US20020169320A1 (en) 2002-11-14
GEP20032926B (en) 2003-03-25
NO20011243D0 (no) 2001-03-12
US20040162310A1 (en) 2004-08-19
CN1560055A (zh) 2005-01-05
PT1115725E (pt) 2003-06-30

Similar Documents

Publication Publication Date Title
IL142063A0 (en) Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same
HUP0200450A3 (en) Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same
HUP0104204A3 (en) Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof
AU2001230892A1 (en) Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HK1031869A1 (en) 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds.
HUP0102313A3 (en) Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates
HUP0101813A3 (en) Carboxylic acid derivatives substituted by homo- or heterocyclic group preparation method and pharmaceutical compositions containing them
IL136145A0 (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
EP0811595A4 (en) HYDROCHALCONE DERIVATIVES, COSMETIC COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING SUCH DERIVATIVES OR COMPOSITIONS
HUP0103913A3 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
HUP9900386A3 (en) Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure
HUP0002171A3 (en) Aminophosphonic acid derivatives, method for their preparation and pharmaceutical compositions thereof
HUP0200816A2 (en) Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases, process for their preparation and pharmaceutical compositions containing them
EP1411056A3 (en) Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for their preparation
IL190120A0 (en) PREPARATION OF 9-AMINO OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a//1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES
HUP0103004A3 (en) Substituted imidazo[1,2a]azines as selective inhibitors of cox-2, process for their preparation and pharmaceutical compositions containing them
HUP0105054A3 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation
PL352280A1 (en) Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
PL328123A1 (en) Derivatives of banzo[c]quinolysine and method of obtaining them
AU5101798A (en) Method for oral administration of buspirone
HUP0001773A3 (en) Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed